Related Experiment Videos
Immune competence assessment in hyperbilirubinemic newborns before and after phototherapy
Insights
Phototherapy for neonatal jaundice does not impair immune response in newborns. Studies show immune function remains stable, suggesting phototherapy is safe even with infections.
Area of Science:
- Neonatal immunology
- Phototherapy research
- Clinical pediatrics
Background:
- Neonatal hyperbilirubinemia is common and can be associated with sepsis.
- Immune competence is crucial for newborns, especially those with infections.
- Phototherapy is a standard treatment for neonatal jaundice, but its effect on immune function requires clarification.
Purpose of the Study:
- To assess immune competence in newborns with hyperbilirubinemia before and after phototherapy.
- To investigate the impact of phototherapy on lymphoproliferative responses and immunoglobulin levels.
- To determine if phototherapy is contraindicated in cases of septic hyperbilirubinemia.
Main Methods:
- Assessed immune competence through lymphoproliferative response to PHA-M.
- Compared responses in hyperbilirubinemic infants, normal infants, and normal adults.
- Measured immunoglobulin M (IgM) and immunoglobulin G (IgG) levels before and after phototherapy.
Main Results:
- Lymphoproliferative response was inhibited in hyperbilirubinemic infants' plasma compared to controls.
- Phototherapy did not appear to inhibit the lymphoproliferative response.
- Post-phototherapy, increased IgM and decreased IgG levels were observed.
Conclusions:
- Phototherapy does not seem to inhibit neonatal immune function.
- Observed changes in IgM and IgG levels warrant further investigation.
- Findings suggest phototherapy may be a safe treatment option for septic hyperbilirubinemia.
Abstract:
Tests for immune competence in normal and hyperbilirubinemic newborns--before and after phototherapy--were assessed. The lymphoproliferative response to PHA-M in hyperbilirubinemic infants was inhibited in the presence of autologous plasma in comparison with normal infants and normal adults. The phototherapy does not seem to inhibit the lymphoproliferative response. After phototherapy, an increased level of IgM and a slight decrease in IgG concentration were found. These data support the possibility that phototherapy is not contraindicated during septic hyperbilirubinemia.